INDIANAPOLIS, Oct. 8, 2025 /PRNewswire/ -- Momentum Life Sciences announces the winners of the premier Patient Support Awards, known as…
Introduction of expanded coaching and advisory services coincides with 2025 American Academy of Ophthalmology Annual Meeting SAN FRANCISCO, Oct. 7,…
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the…
New Predictive Platform Will Use Digital Technology and AI to Assist Clinician Decision-Making BRONX, N.Y., Oct. 6, 2025 /PRNewswire/ -- Serious…
New subscription-based platform empowers a community of Swoop® system users worldwide to access advanced tools in support of imaging research…
SANTA ANA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage…
Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout Preparing for Expansion into Sickle Cell Disease and Acute…
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic…
Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms GAITHERSBURG, MARYLAND / ACCESS Newswire…
Coinciding with 2025 American Academy of Ophthalmology Annual Meeting, the company debuts expanded services and tools for exclusive real-world insights from 85…